- Home
- CAL vs MYGN Comparison
CAL vs MYGN Comparison
Compare CAL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAL | MYGN |
|---|---|---|
| Founded | 1878 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.3M | 444.2M |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CAL | MYGN |
|---|---|---|
| Price | $13.19 | $4.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $15.00 | $7.64 |
| AVG Volume (30 Days) | 528.2K | ★ 918.4K |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $85,513,000.00 | ★ $771,400,000.00 |
| Revenue This Year | $5.19 | $6.86 |
| Revenue Next Year | $2.45 | $5.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.46 | ★ 2.33 |
| 52 Week Low | $8.80 | $3.76 |
| 52 Week High | $17.53 | $8.59 |
Technical Indicators
Market Signals| Indicator | CAL | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 46.44 |
| Support Level | $12.80 | $4.25 |
| Resistance Level | $13.55 | $5.52 |
| Average True Range (ATR) | 0.57 | 0.29 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 32.63 | 36.67 |
Price Performance
Historical ComparisonAbout CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.